For ApoA1, ferritin, IP-10, and SAA1/A2, no significantly different levels were observed at hospital admission – between COVID-19 patients with moderate disease, severe disease or fatal outcome (Figures 2 and S1). This evidence concerns the gene CXCL10 and COVID-19.